Skip to main content

Country Hub

  • Country Portal

Donate

  • Donate

Secondary nav

  • Careers
  • Ethics Hotline
  • Contact us
  • EN
  • FR
Home

Main navigation

Menu
  • Our Alliance
    Our Alliance
    • About
    • Strategy
      • Phase 5 (2021-2025)
        • The equity goal
        • The healthy markets goal
        • The sustainability goal
        • The vaccine goal
      • Phase 4 (2016-2020)
        • The market shaping goal
        • The sustainability goal
        • The systems goal
        • The vaccine goal
      • Phase 3 (2011-2015)
        • The financing goal
        • The health systems goal
        • The market shaping goal
        • The vaccine goal
      • Phase 2 (2006-2010)
      • Phase 1 (2000-2005)
      • Risk management
      • Vaccine investment strategy
      • Gender and immunisation
    • Operating model
      • Gavi's partnership model
        • The Bill & Melinda Gates Foundation
        • UNICEF
        • WHO
        • The World Bank Group
        • Civil society organisations
        • Developing country governments
        • Developing country pharmaceutical industry
        • Industrialised country governments
        • Industralised country pharmaceutical industry
        • Research and technical institutes
      • Gavi's business model
      • Gavi Secretariat
      • Transparency and IATI
    • Governance
      • Gavi Board
        • Board Committees
        • Board composition
        • Board members
        • Board minutes
        • Calendar
      • Governance and legal structures
      • Corporate Policies
      • Audit and Investigations
    • Market Shaping
      • Supply and procurement roadmaps
      • Product information for vaccines and cold chain equipment
      • Vaccine demand forecasting
    • Global Health & Development
      • Decade of vaccine collaboration
      • International Health Partnership for UHC 2030
      • Millennium Development Goals
      • Sustainable Development Goals
      • UN Global Strategy for Women's, Children's and Adolescents' Health
    • Work with us
      • Culture
      • Vacancies
      • Internship programme
      • RFPs and Consulting Opportunities

    Our partnership combines the technical expertise of the development community with the business know-how of the private sector to save children’s lives and protect people’s health by increasing access to immunisation.

     

    FOCUS AREAS Strategy 2016-2020 Partners Our Board Gender and immunisation Sustainable development goals


    CAREERS Current vacancies RFPs and consulting

  • Programmes & Impact
    Programmes & Impact
    • How our support works
      • Support guidelines
        • Apply for vaccine support
        • Apply for health system strengthening support
        • Apply for cold chain equipment support
        • Report on and renew existing Gavi support
        • Access targeted country assistance
        • Additional support guidance documentation
      • Independent Review Committee
      • Joint appraisals
      • Grant performance frameworks
      • Country portal
    • Types of support
      • Vaccine support
        • Human papillomavirus
        • Inactivated polio vaccine
        • Japanese encephalitis
        • Measles and measles-rubella
        • Meningitis A
        • Oral cholera
        • Pentavalent
        • Hepatitis B
        • Haemophilus influenzae type b
        • Pneumococcal
        • Rotavirus
        • Typhoid
        • Yellow fever
      • Health system and immunisation strengthening
        • Immunisation supply chain
        • Data
        • Leadership, management and coordination
        • Demand promotion
      • Partners' engagement framework
        • Targeted country assistance
        • Strategic focus areas
        • Foundational support
      • Making immunisation sustainable
        • Eligibility
        • Transitioning out of Gavi support
        • Co-financing
      • Civil society organisation
    • Country Hub
      • Africa
        • Angola
        • Benin
        • Burkina Faso
        • Burundi
        • Cameroon
        • Central African Republic (the)
        • Chad
        • Comoros
        • Congo
        • Congo, DR
        • Côte d’Ivoire
        • Eritrea
        • Ethiopia
        • Gambia
        • Ghana
        • Guinea
        • Guinea-Bissau
        • Kenya
        • Lesotho
        • Liberia
        • Madagascar
        • Malawi
        • Mali
        • Mauritania
        • Mozambique
        • Niger
        • Nigeria
        • Rwanda
        • Sao Tome and Principe
        • Senegal
        • Sierra Leone
        • South Sudan
        • Tanzania, UR
        • Togo
        • Uganda
        • Zambia
        • Zimbabwe
      • Americas
        • Cuba
        • Haiti
        • Honduras
        • Nicaragua
        • Bolivia
        • Guyana
      • Eastern Mediterranean
        • Afghanistan
        • Djibouti
        • Pakistan
        • Somalia
        • Sudan
        • Yemen
      • Europe
        • Albania
        • Armenia
        • Azerbaijan
        • Bosnia & Herzegovina
        • Georgia
        • Kyrgyzstan
        • Moldova
        • Tajikistan
        • Turkmenistan
        • Ukraine
        • Uzbekistan
      • South-East Asia
        • Bangladesh
        • Bhutan
        • India
        • Indonesia
        • Korea, DPR
        • Myanmar
        • Nepal
        • Sri Lanka
        • Timor Leste
      • Western Pacific
        • Cambodia
        • China
        • Kiribati
        • Lao PDR
        • Mongolia
        • Papua New Guinea
        • Solomon islands
        • Vietnam
    • Our impact
      • Measuring our performance
        • 2011 - 2015 indicators
        • 2016 - 2020 indicators
      • Countries approved for support
      • Disbursements and Commitments
      • Evaluation studies
        • Accelerated Vaccine Introduction project review
        • ADIPs and Hib Initiative Evaluation
        • Baseline study for AMC
        • Co-financing Policy Evaluation
        • Evaluation of Gavi support to CSO 2012
        • Evaluation of Gavi support to CSO 2018
        • Full country evaluations
        • Gavi first evaluation report
        • Gavi second evaluation report
        • Gavi support to Albania evaluation
        • Gavi support to Bosnia and Herzegovina evaluation
        • Gavi-Government of China Hepatitis B vaccination programme
        • Gender policy evaluation
        • Gender policy evaluation 2019
        • Health system strengthening evaluations
        • IFFIm evaluation
        • Immunisation services support evaluation
        • Injection safety support evaluation
        • Measles campaigns in Nigeria
        • Mid-Term Evaluation of MoU8
        • Pneumococcal AMC outcomes and impact evaluation
        • Pneumococcal AMC process and design
        • Review of IRCs
        • Technical assistance through the Partners Engagement Framework evaluation
        • Other studies
      • Facts and figures
      • Progress reports
    • Programmatic Policies
      • Co-financing policy
      • Eligibility and transitioning
      • Fragility, emergencies and refugees policy
      • Gender policy
      • Health system and immunisation strengthening support framework
      • Prioritisation mechanism
      • Risk policy
      • Self-procurement policy
      • Transparency and accountability
      • Vaccine donation policy

    SUPPORTED COUNTRIESSupported countriesGavi supported a total of 73 countries in 2018
    Explore our country hub ->

    FOR COUNTRIES

    Apply for support

    Renew support

     

    OUR RESULTS

    Evaluation studies

    Facts and figures

    Progress reports

  • Investing in Gavi
    Investing in Gavi
    • Funding
      • Overview 2000-2037
      • Current period 2016-2020
      • Donor profiles
        • Al Ansari Exchange
        • Alwaleed Philanthropies
        • Audacious Alliance
        • Australia
        • The Bill & Melinda Gates Foundation
        • Brazil
        • Canada
        • The Children’s Investment Fund Foundation (UK)
        • China Merchants Charitable Foundation
        • China
        • Comic Relief
        • Denmark
        • ELMA Vaccines and Immunization Foundation
        • European Commission
        • France
        • Germany
        • Girl Effect
        • HH Sheikh Mohammed bin Zayed Al Nahyan
        • Iceland
        • India
        • International Federation of Pharmaceutical Wholesalers
        • Ireland
        • Italy
        • Japan
        • Kingdom of Saudi Arabia
        • Kuwait Fund for Arab Economic Development
        • "la Caixa" Banking Foundation
        • LDS Charities
        • Lions Club International Foundation (LCIF)
        • Luxembourg
        • Mastercard
        • The Netherlands
        • Norway
        • Orange
        • Other private donors
        • Principality of Monaco
        • Reckitt Benckiser Group
        • Red Nose Day Fund
        • Republic of Korea
        • Russian Federation
        • South Africa
        • Spain
        • State of Qatar
        • Sultanate of Oman
        • Sweden
        • Switzerland
        • Unilever
        • United Kingdom
        • United States of America
      • Resource mobilisation process
        • Gavi replenishment launch meeting, 30 August 2019
        • Gavi Mid-Term Review, Abu Dhabi high level conference, 10-11 December 2018
        • Gavi pledging conference January 2015
        • Gavi replenishment launch meeting May 2014
        • Gavi Mid-Term Review meeting October 2013
        • Gavi pledging conference June 2011
        • Call for Action and Resources October 2010
        • Financing Country Demand March 2010
    • Partnering with business
      • Financial partnerships
      • Leveraged partnerships
      • Operational partnerships
      • Become a partner
    • Innovative financing
      • IFFIm
      • Pneumococcal AMC
        • AMC legal agreements
        • About
        • How countries can apply
        • How it works
        • Independent Assessment Committee
        • Manufacturers
        • Timeline
      • Gavi Matching Fund
      • Loan buydown
    • INFUSE
      • INFUSE community
      • Call for innovations

    2021-2025 INVESTMENT OPPORTUNITY

    2021-2025 IO

    English   French

    FOCUS AREAS

    Our donors

    Become a partner

    Gavi Matching Fund

  • #VaccinesWork
    #VaccinesWork
    • Country stories
    • Opinions
    • Value of vaccination
      • Added value
      • Cost-effective
      • Health equity
      • Tried and tested
    • Themes / Issues

    FEATURE FOCUS

    Transition Twins

    Sri Lanka and Timor-Leste team up for sustainable immunisation. By 2020, at least 20 developing countries are expected to transition out of Gavi support Read more ->

    FOCUS AREAS

    Tried and tested

  • News & Resources
    News & Resources
    • Media room
      • News releases
    • Document library
      • Evaluations
      • IRC reports
      • Financial reports
    • Publications
    • Audio-visual
      • Videos
      • Galleries
      • Infographics
      • Presentations
    • Archive

    KEY PUBLICATION

    2018 Gavi progress report2018 annual progress report > Download

     

    HEADLINES

    Gavi Board appoints Sarah Goulding as Vice Chair 5 Dec 2019

     

    Gavi Board approves new Ebola vaccine programme 5 Dec 2019

     

    Meet the newest ambassadors for immunisation: 10,000 Karachi schoolgirls 22 Nov 2019

Gavi/2016/Emily Loud
Back to

Europe

Back to

Europe

  • Home
  • Programmes And Impact
  • Country hub
  • Europe

Albania

Learn more

Armenia

Learn more

Azerbaijan

Learn more

Bosnia & herzegovina

Learn more

Georgia

Learn more

Kyrgyzstan

Learn more

Moldova

Learn more

Tajikistan

Learn more

Turkmenistan

Learn more

Ukraine

Learn more

Uzbekistan

Learn more

Countries Gavi supports

Supported Countries

Subscribe to our newsletter

Home

Footer

  • Our Alliance
  • Programmes & impact
  • Investing in Gavi
  • #VaccinesWork
  • News & resources

Country Hub

  • Country Portal

Donate

  • Donate

Footer nav

  • Careers
  • Contact
  • Ethics hotline
  • IFFIm
  • Privacy Policy
  • Terms of use

© Gavi 2019

  • Gavi Email
  • Gavi Twitter
  • Gavi LinkedIn

Our achievements are thanks to the support
and expertise of our founding partners

World Health OrganizationUnicefBill & Melinda GatesThe World Bank